Download PDF Welcome back from the winter break and happy 2021! According to JPMorgan, the outlook of M&A in 2021 is very positive. Indeed, mainly due to a reduction in political uncertainty, the development of vaccines and strong capital markets, there is increased confidence in management and board of directors, Read more…
Kite Pharma (NASDAQ:KITE) – Market cap as of 23/09/2017: $10.28bn Gilead Sciences (NASDAQ:GILD) – Market cap as of 23/09/2017: $108.74bn Introduction On August 28, 2017, Gilead Sciences, Inc. and Kite Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Kite for Read more…
Allergan (AGN) – Market cap as of 07/10/2016: $94.6bn About Allergan Allergan plc is a diversified global pharmaceutical company headquartered in Dublin, Ireland. It is considered to be a leader in “growth pharma”, after its newfound focus on branded pharmaceuticals. Since 2007 Allergan has made a number of acquisitions to Read more…
Bayer AG (BAYN) – market cap as of 24/09/2016: $84.86bn Monsanto Company (MON) – market cap as of 24/09/2016: $45.31bn Introduction On September 14, following months of negotiations, Bayer and Monsanto agreed on a final merger agreement. Bayer will pay $57bn to Monsanto’s shareholders, and will take on $9bn in Read more…